P. De Groote

P. De Groote, F. Mouquet, D. Lacroix, 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Myocardial asynchronism is a determinant of changes in functional mitral regurgitation severity during dynamic exercise in patients with chronic heart failure due to severe left ventricular systolic dysfunction.

T. LeJemtel, N. Lamblin, P. De Groote, 2006, European heart journal.

Anterior Chordal Transection Impairs Not Only Regional Left Ventricular Function But Also Regional Right Ventricular Function in Mitral Regurgitation

P. De Groote, A. Prat, E. Mcfadden, 2001, Circulation.

Accuracy of cardiac magnetic resonance imaging to rule out significant coronary artery disease in patients with systolic heart failure of unknown aetiology: Single-centre experience and comprehensive meta-analysis.

M. Remy-Jardin, M. Fertin, G. Lemesle, 2018, Archives of cardiovascular diseases.

Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis

M. Remy-Jardin, M. Fertin, N. Lamblin, 2013, PloS one.

Comparative Diagnostic Value of Ankle-to-Brachial Index and Transcutaneous Oxygen Tension at Rest and After Exercise in Patients with Intermittent Claudication

P. De Groote, A. Millaire, G. Ducloux, 1995, Angiology.

High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis.

M. Remy-Jardin, P. De Groote, A. Duhamel, 2006, The Journal of rheumatology.

Incidence, determinants and consequences of left atrial remodelling after a first anterior myocardial infarction.

M. Fertin, N. Lamblin, P. De Groote, 2012, Archives of cardiovascular diseases.

Late recovery in left ventricular systolic function after discharge of patients with a first anterior myocardial infarction.

M. Fertin, N. Lamblin, P. De Groote, 2010, Archives of cardiovascular diseases.

Left ventricular remodeling is associated with the severity of mitral regurgitation after inaugural anterior myocardial infarction--optimal timing for echocardiographic imaging.

N. Lamblin, P. De Groote, C. Bauters, 2008, American heart journal.

French recommendations for the management of systemic sclerosis

P. Jégo, P. De Groote, F. Rilliard, 2021, Orphanet Journal of Rare Diseases.

[Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls].

P. De Groote, L. Mouthon, E. Hachulla, 2011, Presse medicale.

Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study

M. Humbert, P. Jégo, P. De Groote, 2008, Rheumatology.

Cardiac Correlates of Exercise Induced Pulmonary Hypertension in Patients with Chronic Heart Failure Due to Left Ventricular Systolic Dysfunction

R. Neviere, T. LeJemtel, P. De Groote, 2008, Echocardiography.

Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with Angiotensin-converting enzyme inhibitors.

N. Lamblin, P. De Groote, C. Bauters, 2003, Chest.

Pulmonary hypertension in chronic heart failure: definitions, advances, and unanswered issues

N. Lamblin, P. De Groote, C. Tribouilloy, 2018, ESC heart failure.

Response of atrial natriuretic factor to surgical pericardial drainage in patients with chronic pericardial effusion.

P. De Groote, A. Millaire, M. Vantyghem, 1994, International journal of cardiology.

Plasma levels of endothelin-1 at rest and after exercise in patients with moderate congestive heart failure.

P. De Groote, A. Millaire, G. Ducloux, 1995, International journal of cardiology.

Epidemiological characteristics and therapeutic management of patients with chronic heart failure who use smartphones: Potential impact of a dedicated smartphone application (report from the OFICSel study).

P. De Groote, F. Bauer, E. Audureau, 2020, Archives of cardiovascular diseases.

Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease.

P. De Groote, B. Jude, F. Puisieux, 2000, The American journal of medicine.

Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: a case-control study.

J. Cesbron, P. De Groote, B. Jude, 1996, American Heart Journal.

Right ventricular systolic function in heart failure: A long story but still the same question.

P. De Groote, 2016, Archives of cardiovascular diseases.

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.

M. Humbert, P. De Groote, G. Simonneau, 2011, Arthritis and rheumatism.

Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial.

P. De Groote, D. Csonka, L. Savale, 2019, The Lancet. Respiratory medicine.

Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.

N. Lamblin, P. De Groote, A. Duhamel, 2010, The American journal of medicine.

Expanding the phenotype associated with a desmoplakin dominant mutation: Carvajal/Naxos syndrome associated with leukonychia and oligodontia.

P. De Groote, P. Charron, D. Bonnet, 2012, International journal of cardiology.

Treatment of recurrent pericarditis with colchicine.

P. De Groote, A. Millaire, P. Groote, 1994, European heart journal.

Malignant pericardial effusions: usefulness of pericardioscopy.

P. De Groote, A. Millaire, P. Groote, 1992, American heart journal.

B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.

N. Lamblin, P. De Groote, C. Bauters, 2004, Journal of the American College of Cardiology.

The external vacuum device in the management of erectile dysfunction.

P. De Groote, P. V. Van Cangh, F. Wese, 1997, Acta urologica Belgica.

Recurrent suspected myocarditis combined with infrahisian conduction disturbances revealing a desminopathy

P. De Groote, P. Charron, P. Richard, 2015, HeartRhythm case reports.

Dual-energy CT lung perfusion in systemic sclerosis: preliminary experience in 101 patients

J. Remy, M. Remy-Jardin, P. De Groote, 2022, European Radiology.

The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients.

N. Lamblin, P. De Groote, F. Mouquet, 2006, American heart journal.

Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment.

M. Humbert, N. Lamblin, P. De Groote, 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.

M. Humbert, E. Fadel, P. De Groote, 2022, The Lancet. Respiratory medicine.

J. Remy, M. Remy-Jardin, M. Fertin, 2022, European Radiology.

Plasma levels of atrial natriuretic peptide at peak exercise: a prognostic marker of cardiovascular-related death and heart transplantation in patients with moderate congestive heart failure.

P. De Groote, A. Millaire, G. Ducloux, 1997, The Journal of Heart and Lung Transplantation.

[Complete radical prostatectomy and positive lymph nodes (stages pT1 to 4, N1 to 3, M0, D1)].

L. Stainier, P. De Groote, J. Cosyns, 1998, Acta urologica Belgica.

Outcome after thrombolytic therapy of nine cases of myopericarditis misdiagnosed as myocardial infarction.

P. De Groote, A. Millaire, G. Ducloux, 1995, European Heart Journal.

Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortality

M. Fertin, N. Lamblin, P. De Groote, 2022, Respiratory Research.

Cardiac Outcomes in Adults With Mitochondrial Diseases.

P. De Groote, V. Procaccio, A. Echaniz-Laguna, 2022, Journal of the American College of Cardiology.

Incidence and prognosis of embolic events and metastatic infections in infective endocarditis.

P. De Groote, A. Millaire, G. Ducloux, 1997, European heart journal.

External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry

M. Humbert, P. De Groote, V. Cottin, 2021, European Respiratory Journal.

Association Between Initial Treatment Strategy and Long-term Survival in Pulmonary Arterial Hypertension.

M. Humbert, P. De Groote, V. Cottin, 2021, American journal of respiratory and critical care medicine.

Cardiac magnetic resonance imaging of mucopolysaccharidosis type II cardiomyopathy.

I. Tillie‐Leblond, P. De Groote, F. Mouquet, 2011, International journal of cardiology.

COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study

P. De Groote, V. Cottin, E. Jutant, 2022, American journal of respiratory and critical care medicine.

[Vasopressin antagonists].

P. De Groote, 2002, Archives des maladies du coeur et des vaisseaux.

Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.

M. Remy-Jardin, P. De Groote, R. Matran, 2007, The Journal of rheumatology.

Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.

P. De Groote, C. Bauters, F. Pinet, 2016, Journal of the American College of Cardiology.

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.

S. Heymans, Y. Pinto, E. Arbustini, 2016, European heart journal.

Bisoprolol in the treatment of chronic heart failure

P. De Groote, F. Mouquet, P. Ennezat, 2007, Vascular health and risk management.

Epidemiology of atrial fibrillation in France: extrapolation of international epidemiological data to France and analysis of French hospitalization data.

J. Le Heuzey, O. Hanon, J. Blacher, 2011, Archives of cardiovascular diseases.

Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients.

P. De Groote, A. Millaire, P. Groote, 1996, Circulation.

[Value of pericardioscopy in pericardial effusion. Apropos of 20 patients].

A. Marquand, P. De Groote, A. Millaire, 1988, Archives des maladies du coeur et des vaisseaux.

Atrial fibrillation and renin-angiotensin-aldosterone system: believe it or not.

L. Fauchier, P. De Groote, 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure.

X Marchandise, G Ducloux, P. De Groote, 1998, Journal of the American College of Cardiology.

Prevalence of memory disorders in ambulatory patients aged ≥70 years with chronic heart failure (from the EFICARE study).

M. Komajda, O. Hanon, P. De Groote, 2014, The American journal of cardiology.

Impact of diabetes mellitus on long-term survival in patients with congestive heart failure.

N. Lamblin, P. De Groote, F. Mouquet, 2004, European heart journal.

Consensus of the French Society of Gerontology and Geriatrics and the French Society of Cardiology for the management of coronary artery disease in older adults.

M. Komajda, O. Hanon, P. De Groote, 2009, Archives of cardiovascular diseases.

[Cardiovascular manifestations caused by Mycoplasma pneumoniae. Apropos of a case of recurrent pericarditis complicated by tamponade].

P. De Groote, A. Millaire, G. Ducloux, 1995, Annales de cardiologie et d'angeiologie.

Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure

P. Amouyel, N. Lamblin, P. De Groote, 2005, Pharmacogenetics and genomics.

Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists.

A. Cohen-Solal, A. Mebazaa, C. Leclercq, 2014, Archives of cardiovascular diseases.

Iron deficiency: an emerging therapeutic target in heart failure

A. Cohen-Solal, A. Mebazaa, C. Leclercq, 2014, Heart.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

M. Humbert, P. De Groote, V. Cottin, 2017, European Respiratory Journal.

Influence of diabetes mellitus on heart failure risk and outcome

N. Lamblin, P. De Groote, C. Bauters, 2003, Cardiovascular diabetology.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients

N. Lamblin, P. De Groote, A. Hachulla, 2008, Annals of the rheumatic diseases.

Urodynamic and electrophysiological testing in pediatric neurourology.

P. De Groote, P. Clapuyt, P. V. Van Cangh, 1998, Acta urologica Belgica.

[Value of spiral computed tomography with three-dimensional reconstruction in the investigation of renal arteries. An initial clinical experience apropos of 16 cases].

P. De Groote, J. Beregi, A. Millaire, 1996, Archives des maladies du coeur et des vaisseaux.

Treatment of heart failure with preserved systolic function.

M. Komajda, O. Hanon, P. De Groote, 2008, Archives of cardiovascular diseases.

Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction

P. Amouyel, P. De Groote, C. Bauters, 2019, Scientific Reports.

A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-aldosterone, adrenergic, and metalloproteinase systems.

P. Amouyel, N. Lamblin, P. De Groote, 2007, American heart journal.

Factors associated with the 6-minute walk distance in patients with systemic sclerosis

N. Lamblin, P. De Groote, J. Giovannelli, 2017, Arthritis Research & Therapy.

Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome.

M. Humbert, P. De Groote, L. Mouthon, 2010, Rheumatology.

A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension

M. Humbert, S. Leroy, P. De Groote, 2015, Annals of the rheumatic diseases.

Long-Term Functional and Clinical Follow-Up of Patients With Heart Failure With Recovered Left Ventricular Ejection Fraction After &bgr;-Blocker Therapy

M. Fertin, N. Lamblin, P. De Groote, 2014, Circulation. Heart failure.

A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction.

G. Lemesle, N. Lamblin, P. De Groote, 2016, International journal of cardiology.

Multimarker Proteomic Profiling for the Prediction of Cardiovascular Mortality in Patients with Chronic Heart Failure

P. Amouyel, G. Lemesle, N. Lamblin, 2015, PloS one.

Prevalence and determinants of cognitive impairment in chronic heart failure patients.

D. Leys, F. Pasquier, N. Lamblin, 2007, Congestive heart failure.

Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: comparison of radionuclide angiography to echoDoppler parameters.

M. Fertin, N. Lamblin, P. De Groote, 2012, European heart journal.

Apolipoprotein Proteomic Profiling for the Prediction of Cardiovascular Death in Patients with Heart Failure

P. Amouyel, V. Chouraki, A. Turkieh, 2020, Proteomics. Clinical applications.

Prescription, Compliance, and Burden Associated with Salt-Restricted Diets in Heart Failure Patients: Results from the French National OFICSel Observatory

P. De Groote, E. Audureau, D. Logeart, 2022, Nutrients.

New technologies, new therapies: toward personalized medicine in heart failure patients?

P. De Groote, C. Bauters, F. Pinet, 2013, European heart journal.

Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice

M. Fertin, N. Lamblin, P. De Groote, 2017, PloS one.

Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patients.

G. Lemesle, N. Lamblin, P. De Groote, 2017, Archives of cardiovascular diseases.

Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus

M. Fertin, N. Lamblin, P. De Groote, 2012, Journal of cardiovascular medicine.

Left ventricular remodeling and heart failure after myocardial infarction in elderly patients.

N. Lamblin, P. De Groote, C. Bauters, 2010, The American journal of cardiology.

Rationale and design of the CardioMEMS Post‐Market Multinational Clinical Study: COAST

P. De Groote, M. Cowie, P. Adamson, 2020, ESC heart failure.

Effects of bisoprolol in patients with stable congestive heart failure.

N. Lamblin, P. De Groote, C. Bauters, 2004, Annales de cardiologie et d'angeiologie.

Initial dual oral combination therapy in pulmonary arterial hypertension

M. Humbert, P. De Groote, V. Cottin, 2016, European Respiratory Journal.

Vericiguat for the treatment of heart failure: mechanism of action and pharmacological properties compared with other emerging therapeutic options

P. De Groote, J. Trochu, E. Donal, 2021, Expert opinion on pharmacotherapy.

Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis

M. Humbert, J. Cracowski, N. Lamblin, 2007, Annals of the rheumatic diseases.

Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest.

R. Neviere, T. LeJemtel, P. De Groote, 2008, Journal of cardiac failure.

The effect of ageing on cardiac remodelling and hospitalization for heart failure after an inaugural anterior myocardial infarction.

P. Quandalle, N. Lamblin, P. De Groote, 2008, European heart journal.

French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes

P. De Groote, T. Leblanc, V. Cottin, 2023, Orphanet Journal of Rare Diseases.

Cardiac resynchronisation therapy reduces functional mitral regurgitation during dynamic exercise in patients with chronic heart failure: an acute echocardiographic study

A. Cohen-Solal, T. LeJemtel, P. De Groote, 2005, Heart.

Sildenafil in heart transplant candidates with pulmonary hypertension.

M. Fertin, N. Lamblin, P. De Groote, 2015, Archives of cardiovascular diseases.

Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension

M. Humbert, E. Fadel, P. De Groote, 2023, Circulation.

Efficiency of disopyramide in hypertrophic cardiomyopathy during stress states.

Y. Houdas, P. De Groote, A. Millaire, 1992, The American journal of cardiology.

[Assessment of plasma endothelin level measurement in systemic sclerosis].

P. De Groote, E. Hachulla, P. Hatron, 2007, La Revue de medecine interne.

Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital

P. De Groote, B. Décaudin, P. Odou, 2021, European journal of hospital pharmacy : science and practice.

Heart failure with preserved systolic function: a diagnostic algorithm for a pragmatic definition.

M. Komajda, O. Hanon, P. De Groote, 2006, Archives des maladies du coeur et des vaisseaux.

Cytokines as prognostic biomarkers in pulmonary arterial hypertension

M. Humbert, P. De Groote, X. Jaïs, 2022, European Respiratory Journal.

[Aortitis in Horton disease. Review of the literature].

P. De Groote, A. Millaire, G. Ducloux, 1996, Annales de medecine interne.

[Heart valve involvement in lupus erythematosus disseminatus. Apropos of 2 cases. Review of the literature].

A. Marquand, P. De Groote, A. Millaire, 1989, Annales de cardiologie et d'angeiologie.

Obstruction of the left main coronary ostium due to an aortic vegetation: survival after early surgery.

P. De Groote, A. Millaire, G. Ducloux, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Involvement of BAG3 and HSPB7 loci in various etiologies of systolic heart failure: Results of a European collaboration assembling more than 2000 patients.

Karen S. Frese, L. Fauchier, C. Hengstenberg, 2013, International journal of cardiology.

Multicentric randomized evaluation of a tricuspid valve percutaneous repair system (clip for the tricuspid valve) in the treatment of severe secondary tricuspid regurgitation Tri.Fr Design paper.

P. De Groote, E. Oger, J. Trochu, 2021, European heart journal. Cardiovascular Imaging.

Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty?

P. De Groote, C. Bauters, C. Delcayre, 1992, European heart journal.

Relative impact of bleedings over ischaemic events in patients with heart failure: insights from the CARDIONOR registry

G. Lemesle, N. Lamblin, P. De Groote, 2020, ESC heart failure.

Assessment of potential heart donors: A statement from the French heart transplant community.

P. De Groote, J. Amour, F. Bauer, 2017, Archives of cardiovascular diseases.

Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure

G. Lemesle, P. De Groote, C. Bauters, 2014, Circulation research.

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

M. Humbert, P. De Groote, V. Cottin, 2017, European Respiratory Journal.

Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.

N. Lamblin, P. De Groote, A. Duhamel, 2010, The American journal of medicine.

Influence of diabetes mellitus on heart failure risk and outcome

N. Lamblin, P. De Groote, C. Bauters, 2003, Cardiovascular diabetology.

2D-speckle tracking right ventricular strain to assess right ventricular systolic function in systolic heart failure. Analysis of the right ventricular free and posterolateral walls.

M. Fertin, N. Lamblin, P. De Groote, 2017, International journal of cardiology.

[Current respective role of surgery and permanent endocavitary stimulation in the treatment of hypertrophic cardiomyopathies].

P. De Groote, A. Millaire, G. Ducloux, 1995, Annales de cardiologie et d'angeiologie.

Percutaneous transaortic valve implantation for severe aortic regurgitation in a patient with a porto-pulmonary hypertension.

M. Fertin, N. Lamblin, P. De Groote, 2015, International journal of cardiology.